글로벌 불안다리증후군 시장 – 2028년까지의 산업 동향 및 예측

불안 다리 증후군 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 불안다리증후군이 2021-2028년 예측 기간 동안 약 6.70%의 CAGR을 보일 것이라고 분석했습니다. 표적 치료 모드에 대한 수요 증가, 신약 및 치료법 개발을 위한 연구 개발 활동 급증, 충족되지 않은 높은 치료 요구 및 의료 인프라 개발에 대한 지출 증가 는 불안다리증후군 시장 성장에 기인하는 주요 요인입니다.

윌리스 엑봄병이라고도 알려진 불안다리증후군은 다리를 계속 움직여야 하는 엄청난 욕구를 유발하는 신경계 질환으로, 다리에 욱신거리는 감각을 유발합니다. 이 증상은 사람이 앉아 있거나 누워 있을 때 가장 심해집니다. 불안다리증후군은 유전적 요인과 환경적 요인이 결합된 결과입니다.

전 세계적으로 신경계 질환의 유병률이 증가하는 것은 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가 와 시장 참여자 간의 전략적 협력 비율의 급증은 시장 성장을 촉진하는 다른 요인입니다. 개인의 가처분 소득 증가와 유전 질환의 유병률 증가는 수익성 있는 시장 성장 기회를 창출할 또 다른 간접적인 결정 요인입니다.

그러나 제네릭 약물의 도입 증가와 불리한 환불 시나리오는 시장 성장에 큰 도전이 될 것입니다. 또한, 연구 개발 능력과 관련된 높은 비용과 숙련된 전문가의 부족이 시장 성장률을 더욱 떨어뜨릴 것입니다. 브랜드 약물의 특허 만료도 시장 성장률을 방해할 것입니다.

This restless leg syndrome market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on restless leg syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Restless Leg Syndrome Market Scope and Market Size

The restless leg syndrome market is segmented on the basis of type, therapy type, treatment type, drugs, route of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the restless leg syndrome market is segmented into primary restless legs syndrome and secondary restless legs syndrome.
• On the basis of therapy type, the restless leg syndrome market is segmented into pharmacological therapies and non-pharmacological therapies.
• On the basis of treatment type, the restless leg syndrome market is segmented into medication and surgery.
• On the basis of drugs, the restless leg syndrome market is segmented into dopaminergic agents, anti-seizure agent, benzodiazepines, opioids and others. Dopaminergic agents segment is sub-segmented into pramipexole, ropinirole and rotigotine. Anti-seizure agent segment is sub-segmented into gabapentin. Benzodiazepines segment is sub-segmented into clonazepam. Opioids segment is sub-segmented into codeine and propoxyphene.
• On the basis of route of administration, the restless leg syndrome market is segmented into oral and injectable.  
• On the basis of end users, the restless leg syndrome market is segmented into hospitals, home care, speciality clinics and others.

Restless Leg Syndrome Market Country Level Analysis

The restless leg syndrome market is analysed and market size insights and trends are provided by country, type, therapy type, treatment type, drugs, route of administration and end users as referenced above.

The countries covered in the restless leg syndrome market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the restless leg syndrome market owing to the rising affordability of drugs and surge in the awareness about the availability of treatment options. Asia-Pacific is projected to score highest growth rate and exhibit the CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure and growing prevalence of neurological disorders.

The country section of the restless leg syndrome market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The restless leg syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Restless Leg Syndrome Market Share Analysis

The restless leg syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to restless leg syndrome market.

불안 다리 증후군 시장 보고서에 포함된 주요 기업으로는 GlaxoSmithKline plc, Ligand Pharmaceuticals Incorporated, Jazz Pharmaceuticals, Inc., Hisamitsu Pharmaceutical Co., Inc., Intas Pharmaceuticals Ltd, Serina Therapeutics, Apotex Inc, Teva Pharmaceutical Industries Ltd, Mylan NV, Glenmark Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, Endo Pharmaceuticals Inc., Novartis AG, Aurobindo Pharma, Zydus Cadila, Dr. Reddy's Laboratories Ltd, Alembic Pharmaceuticals Limited, Macleods Pharmaceuticals Ltd, Unichem Laboratories, Boehringer Ingelheim International GmbH 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-48015